Steven Balk
Director, DNA Sequencing, Quantitative RT-PCR, Laser Capture Microdissection Core Facilities, BIDMC: 2000-Present · Beth Israel Deaconess Medical Center
Credentials: · · ·
History
- Present
DNA Sequencing · Beth Israel Deaconess Medical Center
- 1986–1989
Hematology and Medical Oncology
- 1983–1986
Internal Medicine
Research
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
New England Journal of Medicine · 1995 · Last of 8 authors · 1,019 citations
Cancer Research · 2006 · Last of 8 authors · 883 citations
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Cell · 2009 · 758 citations
41 papers
32 papers
31 papers
27 papers
- JR
25 papers · 10 as a resident
- HY
23 papers
- PK
23 papers
21 papers
Grants
- 2013–2030
Androgen Receptor Action in Castration Resistant Prostate Cancer
National Cancer Institute · P01
Contact PI · $22.3M · Beth Israel Deaconess Medical Center
- 2023–2028
- 2023–2028
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
National Cancer Institute · R01
Contact PI · $1.6M · Beth Israel Deaconess Medical Center
- 2022–2027
Enhancing the Efficacy of Docetaxel in Prostate Cancer
National Cancer Institute · R01
Contact PI · $3.2M · Beth Israel Deaconess Medical Center
Clinical trials
- 2008–2015
In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer
Principal investigator · Completed · Phase 1
Beth Israel Deaconess Medical Center
- 2005–2012
Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center